GILD - Gilead Sciences, Inc.
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
United States
650 574 3000
https://www.gilead.com
Sector(s): Healthcare
Industry: Drug Manufacturers—General
Full-time employees: 17,000
Key executives
| Name | Title | Pay | Exercised | Year born |
|---|---|---|---|---|
| Mr. Daniel P. O'Day | Chairman & CEO | 7.27M | N/A | 1964 |
| Mr. Andrew D. Dickinson | Exec. VP & CFO | 2.94M | N/A | 1970 |
| Ms. Deborah H. Telman | Exec. VP of Corp. Affairs, Gen. Counsel & Corp. Sec. | 2.32M | N/A | 1965 |
| Ms. Johanna Mercier | Chief Commercial Officer | 3.32M | N/A | 1970 |
| Dr. Merdad V. Parsey M.D., Ph.D. | Chief Medical Officer | 3.07M | N/A | 1963 |
| Ms. Sandra Patterson | Sr. VP, Corp. Controller & Principal Accounting Officer | N/A | N/A | 1967 |
| Ms. Jacquie Ross C.F.A. | VP of Investor Relations | N/A | N/A | N/A |
| Ms. Jyoti K. Mehra | Exec. VP of HR | N/A | N/A | 1976 |
| Dr. Michael Quigley Ph.D. | Sr. VP of Research Biology | N/A | N/A | N/A |
| Dr. Linda Slanec Higgins Ph.D. | Sr. VP of Research, Innovation & Portfolio | N/A | N/A | 1962 |
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Corporate governance
Gilead Sciences, Inc.’s ISS governance QualityScore as of 1 May 2023 is 1. The pillar scores are Audit: 2; Board: 5; Shareholder rights: 1; Compensation: 3.
